Cell-free fetal DNA in plasma of pregnant women: Clinical potential and origin

Taiwanese Journal of Obstetrics and Gynecology

Volumn 44, Issue 2, 2005, Pages 116-122

  Sekizawa, Akihiko ^a   Farina, Antonio ^a   Okai, Takashi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fetal DNA; Genetic testing; Plasma

Indexed keywords

DNA; FETAL DNA; RHESUS D ANTIGEN; UNCLASSIFIED DRUG;

BLOOD GROUP RHESUS SYSTEM; DNA DETERMINATION; FETUS CELL; GENETIC DISORDER; GENETIC SCREENING; HUMAN; HYPEREMESIS GRAVIDARUM; MATERNAL PLASMA; PLACENTA ACCRETA; PLACENTA VILLUS; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL DIAGNOSIS; PRENATAL SCREENING; REVIEW; SEX DETERMINATION; SINGLE GENE DISORDER; TRISOMY 21; TROPHOBLAST;

EID: 22144479064     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(09)60122-4     Document Type: Review

References (48)

1. Teshima IE, Kalousek DK, Vekemans MJ, et al. Canadian multicenter randomized clinical trial of chorion villus sampling and amniocentesis. chromosome mosaicism in CVS and amniocentesis samples. Prenat Diagn 1992;12:443-66.
2. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996;93: 705-8.
3. DeMaria MA, Zheng YL, Zhen D, Weinschenk NM, Vadnais TJ, Bianchi DW. Improved fetal nucleated erythrocyte sorting purity using intracellular antifetal hemoglobin and Hoechst 33342. Cytometry 1996;25:37-45.
4. Sekizawa A, Samura O, Zhen DK, Falco V, Bianchi DW. Fetal cell recycling: diagnosis of gender and RhD genotype in the same fetal cell retrieved from maternal blood. Am J Obstet Gynecol 1999;181:1237-42.
5. Ganshirt D, Borjesson-Stoll R, Burschyk M, et al. Successful prenatal diagnosis from maternal blood with magnetic-activated cell sorting. Ann N Y Acad Sci 1994;731:103-14.
6. Kitagawa M, Sugiura K, Omi H, et al. New technique using galactose-specific lectin for isolation of fetal cells from maternal blood. Prenat Diagn 2002;22:17-21.
7. Takabayashi H, Kuwabara S, Ukita T, Ikawa K, Yamafuji K, Igarashi T. Development of non-invasive fetal DNA diagnosis from maternal blood. Prenat Diagn 1995;15:74-7.
8. Sekizawa A, Kimura T, Sasaki M, Nakamura S, Kobayashi R, Sato T. Prenatal diagnosis of Duchenne muscular dystrophy using a single fetal nucleated erythrocyte in maternal blood. Neurology 1996;46:1350-3.
9. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 1997;61:822-9.
10. Bianchi DW, Simpson JL, Jackson LG, et al. Fetal cells in maternal blood: NIFTY clinical trial interim analysis. DM-STAT. NICHD fetal cell study (NIFTY) group. Prenat Diagn 1999;19:994-5.
11. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
12. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62: 768-75.
13. Sekizawa A, Kondo T, Iwasaki M, Watanabe A, Jimbo M, Saito H, Okai T. Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin Chem 2001;47: 1856-8.
14. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64:218-24.
15. Lo YM, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-8.
16. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000;356:1170.
17. Shiang R, Thompson LM, Zhu YZ, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994;78: 335-42.
18. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000;46:301-2.
19. Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ, et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 2002;22:946-8.
20. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002;360:998-1000.
21. Chiu RW, Lau TK, Cheung PT, Gong ZQ, Leung TN, Lo YM. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 2002;48:778-80.
22. Lo YM, Leung TN, Tein MS, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184-8.
23. Zhong XY, Holzgreve W, Hahn S. Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia. Ann NY Acad Sci 2001;945:138-40.
24. Sekizawa A, Jimbo M, Saito H, Iwasaki M, Matsuoka R, Okai T, Farina A. Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 2003;188:480-4.
25. Caramelli E, Rizzo N, Concu M, et al. Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction - a pilot study. Prenat Diagn 2003;23:367-71.
26. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001;357:53-6.
27. Sekizawa A, Yokokawa K, Sugito Y, et al. Evaluation of bidirectional transfer of plasma DNA through placenta. Hum Genet 2003;113:307-10.
28. Sekizawa A, Farina A, Koide K, et al. Beta-globin DNA in maternal plasma as a molecular marker of preeclampsia. Prenat Diagn 2004;24:697-700.
29. Leung TN, Zhang J, Lau TK, Chan LY, Lo YM. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001;47:137-9.
30. Farina A, Sekizawa A, Iwasaki M, Matsuoka R, Ichizuka K, Okai T. Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening. Prenat Diagn 2004;24:722-6.
31. Sekizawa A, Sugito Y, Iwasaki M, et al. Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum. Clin Chem 2001;47:2164-5.
32. Sugito Y, Sekizawa A, Farina A, et al. Relationship between severity of hyperemesis gravidarum and fetal DNA concentration in maternal plasma. Clin Chem 2003;49:1667-9.
33. Minagawa M, Narita J, Tada T, et al. Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system. Cell Immunol 1999;196: 1-13.
34. Sekizawa A, Jimbo M, Saito H, et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem 2002;48:353-4.
35. Jimbo M, Sekizawa A, Sugito Y, Matsuoka R, Ichizuka K, Saito H, Okai T. Placenta increta: postpartum monitoring of plasma cell-free fetal DNA. Clin Chem 2003;49:1540-1.
36. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 1998;352:1904-5.
37. Farina A, LeShane E, Romero R, Gomez R, Chaiworapongsa T, Rizzo N, Bianchi D. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2005. [In press]
38. Lo YM, Lau TK, Zhang J, et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 1999;45:1747-51.
39. Zhong XY, Burk MR, Troeger C, Jackson LR, Holzgreve W, Hahn S. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 2000;20:795-8.
40. Farina A, LeShane ES, Lambert-Messerlian GM, et al. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem 2003;49:239-42.
41. Ohashi Y, Miharu N, Honda H, Samura O, Ohama K. Quantitation of fetal DNA in maternal serum in normal and aneuploid pregnancies. Hum Genet 2000;108:123-7.
42. Sekizawa A, Samura O, Zhen DK, Falco V, Farina A, Bianchi DW. Apoptosis in fetal nucleated erythrocytes circulating in maternal blood. Prenat Diagn 2000;20:886-9.
43. Kondo T, Sekizawa A, Saito H, Jimbo M, Sugito Y, Okai T. Fate of fetal nucleated erythrocytes circulating in maternal blood: apoptosis is induced by maternal oxygen concentration. Clin Chem 2002;48:1618-20.
44. Angert RM, LeShane ES, Lo YM, Chan LY, Delli-Bovi LC, Bianchi DW. Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection: analysis of first- and third-trimester samples. Clin Chem 2003;49: 195-8.
45. Al-Mufti R, Lees C, Albaiges G, Hambley H, Nicolaides KH. Fetal cells in maternal blood of pregnancies with severe fetal growth restriction. Hum Reprod 2000;15:218-21.
46. Hoesli I, Danek M, Lin D, Li Y, Hahn S, Holzgreve W. Circulating erythroblasts in maternal blood are not elevated before onset of preterm labor. Obstet Gynecol 2002;100: 992-6.
47. Loke YW, King A. Immunology of human placental implantation: clinical implications of our current understanding. Mol Med Today 1997;3:153-9.
48. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002;186:158-66.